179 related articles for article (PubMed ID: 4777598)
1. Proceedings: The line-up on bioavailability.
Schneller GH
Rev Can Biol; 1973; 32():Suppl:151-5. PubMed ID: 4777598
[No Abstract] [Full Text] [Related]
2. Bioavailability of peroral dosage forms.
Ritschel WA
Boll Chim Farm; 1973 Mar; 112(3):137-62. PubMed ID: 4198518
[No Abstract] [Full Text] [Related]
3. Proceedings: Bioavailability and therapeutic efficacy.
Withey RJ
Rev Can Biol; 1973; 32():Suppl:21-30. PubMed ID: 4777602
[No Abstract] [Full Text] [Related]
4. Drug formulation and biologic availability.
Poole JW
Semin Drug Treat; 1971 Sep; 1(2):148-76. PubMed ID: 5153883
[No Abstract] [Full Text] [Related]
5. Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1973 Nov; 536():1-17. PubMed ID: 4204708
[No Abstract] [Full Text] [Related]
6. Bioavailability of drugs (second of two parts).
Koch-Weser J
N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153
[No Abstract] [Full Text] [Related]
7. Some factors affecting bioavailability of drug products.
Lach JL
J Iowa Med Soc; 1972 Aug; 62(8):441-2 passim. PubMed ID: 5044776
[No Abstract] [Full Text] [Related]
8. Bioavailability of digoxin in man after oral administration of preparations with different dissolution rate.
Nyberg L
Acta Pharmacol Toxicol (Copenh); 1977; 40 Suppl 3():1-48. PubMed ID: 301340
[No Abstract] [Full Text] [Related]
9. Basics of Sterile Compounding: Biopharmaceutics of Injectable Dosage Forms.
Akers MJ
Int J Pharm Compd; 2017; 21(1):47-56. PubMed ID: 28346198
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic non-equivalence.
Br Med J; 1972 Sep; 3(5827):599-600. PubMed ID: 5071688
[No Abstract] [Full Text] [Related]
11. [Drug dosage form and action].
Zathurecký L
Med Klin; 1974 Apr; 69(16):667-70. PubMed ID: 4837397
[No Abstract] [Full Text] [Related]
12. Keeping bioavailability in perspective.
Schumacher GE
Am J Hosp Pharm; 1973 Feb; 30(2):150-4. PubMed ID: 4690469
[No Abstract] [Full Text] [Related]
13. Recent changes in biological availability of digoxin. Effect of an alteration in 'Lanoxin' tablets.
Shaw TR; Howard MR; Hamer J
Br Heart J; 1974 Jan; 36(1):85-9. PubMed ID: 4818143
[No Abstract] [Full Text] [Related]
14. The bioavailability of digoxin.
Lancet; 1972 Aug; 2(7772):311-2. PubMed ID: 4115037
[No Abstract] [Full Text] [Related]
15. Bioavailability and digoxin.
N Z Med J; 1972 Sep; 76(484):203. PubMed ID: 4508750
[No Abstract] [Full Text] [Related]
16. Some aspects of the influence of formulation on the bioavailability of drugs from solid dosage forms.
Corrigan OI; Timoney RF
Ir J Med Sci; 1974 Jul; 143(4):197-207. PubMed ID: 4605123
[No Abstract] [Full Text] [Related]
17. Importance of biopharmaceutics and pharmacokinetics in clinical medicine.
Cabana BE
Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability, clinical effectiveness, and the public interest.
Levy G
Pharmacology; 1972; 8(1):33-43. PubMed ID: 4644654
[No Abstract] [Full Text] [Related]
19. Bioavailability of drugs (first of two parts).
Koch-Weser J
N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
[No Abstract] [Full Text] [Related]
20. Dissolution-rates and bioavailability of digoxin tablets.
Fraser EJ; Leach RH; Poston JW; Bold AM; Culank LS; Lipede AB
Lancet; 1973 Jun; 1(7816):1393. PubMed ID: 4122785
[No Abstract] [Full Text] [Related]
[Next] [New Search]
